Exclusive

Publication

Byline

Location

US Patent Issued to CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT POLYTECHNIQUE DE BORDEAUX, Ecole Nationale Superieure de Chimie de Paris, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE DE BORDEAUX, UNIVERSITE PARIS CITE on Oct. 27 for "Stimuli - or bio-responsive copolymers, the polymersomes comprising the same and their use in drug delivery" (French, Hungarian, Israeli Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,388, issued on Oct. 27, was assigned to CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (Paris), INSTITUT POLYTECHNIQUE DE BORDEAUX (Talence, F... Read More


US Patent Issued to CONTERA PHARMA on Oct. 27 for "Pulsatile drug delivery system for treating morning akinesia" (Danish Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,389, issued on Oct. 27, was assigned to CONTERA PHARMA A/S (Horsholm, Denmark). "Pulsatile drug delivery system for treating morning akines... Read More


US Patent Issued to Wisconsin Alumni Research Foundation on Oct. 27 for "Compositions and methods for treating cancer" (Wisconsin Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,390, issued on Oct. 27, was assigned to Wisconsin Alumni Research Foundation (Madison, Wis.). "Compositions and methods for treating cancer... Read More


US Patent Issued to Merck Sharp & Dohme on Oct. 27 for "Lipid nanoparticle compositions containing monoester cationic lipids" (New Jersey, Pennsylvania Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,391, issued on Oct. 27, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.). "Lipid nanoparticle compositions containing monoester catio... Read More


US Patent Issued to LTS LOHMANN THERAPIE-SYSTEME on Oct. 27 for "Oral thin film comprising a PVA-tris buffer layer" (German Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,392, issued on Oct. 27, was assigned to LTS LOHMANN THERAPIE-SYSTEME AG (Andernach, Germany). "Oral thin film comprising a PVA-tris buffer ... Read More


US Patent Issued to Compagnie Gervais Danone, Universite Laval on Oct. 27 for "Composition for reducing hepatic triglycerides and/or improving glucose metabolism" (Canadian, French Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,393, issued on Oct. 27, was assigned to Compagnie Gervais Danone (Paris) and Universite Laval (Quebec, Canada). "Composition for reducing h... Read More


US Patent Issued to SANTEN PHARMACEUTICAL, SINGAPORE HEALTH SERVICES on Oct. 27 for "Use of valproic acid for reducing post-operative scarring following a glaucoma surgery" (Singaporean Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,394, issued on Oct. 27, was assigned to SANTEN PHARMACEUTICAL Co. LTD. (Osaka, Japan) and SINGAPORE HEALTH SERVICES PTE LTD (Singapore). "U... Read More


US Patent Issued to INSTITUTE NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONMENT, INSTITUT NATIONAL DES SCIENCES ET INDUSTRIES DU VIVANT ET DE L'ENVIRONMENT, UNIVERSITE PARIS-SACLAY on Oct. 27 for "O-acetylserine for the use thereof in the prevention and treatment of glucose intolerance and the associated diseases" (French Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,395, issued on Oct. 27, was assigned to INSTITUTE NATIONAL DE RECHERCHE POUR L'AGRICULTURE L'ALIMENTATION ET L'ENVIRONMENT (Paris), INSTITUT... Read More


US Patent Issued to Alkermes Pharma Ireland on Oct. 27 for "Prodrugs of fumarates and their use in treating various diseases" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,396, issued on Oct. 27, was assigned to Alkermes Pharma Ireland Ltd. (Dublin). "Prodrugs of fumarates and their use in treating various dis... Read More


US Patent Issued on Oct. 27 for "Treatment of serotonin reuptake inhibitor withdrawal syndrome" (Israeli Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,397, issued on Oct. 27. "Treatment of serotonin reuptake inhibitor withdrawal syndrome" was invented by Mark Hasleton (Raanana, Israel). A... Read More